Arrdc1 Polyclonal Antibody

ARRDC1, ARRDC2 (which exists as multiple alternatively spliced isoforms), ARRDC4 and ARRDC5 are arrestin domain-containing proteins that are encoded by genes which map to human chromosomes 9, 15 and 19. Chromosome 9, on which the ARRDC1 gene is localized, contains 145 million base pairs and comprises 4% of the human genome,

encoding nearly 900 genes. Hereditary hemorrhagic telangiectasia, which is characterized by harmful vascular defects, and Familial dysautonomia, are both associated with chromosome 9. Notably, chromosome 9 encompasses the largest interferon family gene cluster. The ARRDC2 and ARRDC5 genes map to chromosome 19, which consists of over 63 million bases, houses approximately 1,400 genes and is recognized for having the greatest gene density of the human chromosomes. Unlike other ARRDC genes, the ARRDC4 gene maps to human chromosome 15, which houses over 700 genes and comprises nearly 3% of the human genome. Angelman syndrome, Prader-Willi syndrome, Tay-Sachs disease and Marfan syndrome are all associated with defects in chromosome 15-localized genes.

The ARRDC2 Polyclonal Antibody is a highly specific and sensitive antibody designed for use in various research applications. This antibody is produced using high-quality materials and advanced techniques to ensure optimal performance and reliability. It is designed to target the ARRDC2 protein, which is involved in various cellular processes, including cell proliferation, differentiation, and apoptosis. The ARRDC2 Polyclonal Antibody is suitable for use in various techniques, including Western blotting, immunohistochemistry, and immunofluorescence. It is available in various sizes and formats to meet the specific needs of different research applications. This antibody is an essential tool for researchers studying the role of ARRDC2 in various biological processes and diseases. Its high specificity and sensitivity make it an ideal choice for accurate and reliable detection of ARRDC2 protein in various samples.